Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study by Houston, Thomas K. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Population and Quantitative Health Sciences 
Publications Population and Quantitative Health Sciences 
2006-04-11 
Active and passive smoking and development of glucose 
intolerance among young adults in a prospective cohort: CARDIA 
study 
Thomas K. Houston 
University of Alabama 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/qhs_pp 
 Part of the Bioinformatics Commons, Biostatistics Commons, Epidemiology Commons, and the 
Health Services Research Commons 
Repository Citation 
Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. (2006). Active and passive smoking and 
development of glucose intolerance among young adults in a prospective cohort: CARDIA study. 
Population and Quantitative Health Sciences Publications. https://doi.org/10.1136/bmj.38779.584028.55. 
Retrieved from https://escholarship.umassmed.edu/qhs_pp/52 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Population and 
Quantitative Health Sciences Publications by an authorized administrator of eScholarship@UMMS. For more 
information, please contact Lisa.Palmer@umassmed.edu. 
Research
Active and passive smoking and development of glucose intolerance
among young adults in a prospective cohort: CARDIA study
Thomas K Houston, Sharina D Person, Mark J Pletcher, Kiang Liu, Carlos Iribarren, Catarina I Kiefe
Abstract
Objective To assess whether active and passive smokers are
more likely than non-smokers to develop clinically relevant
glucose intolerance or diabetes.
Design Coronary artery risk development in young adults
(CARDIA) is a prospective cohort study begun in 1985-6 with
15 years of follow-up.
Setting Participants recruited from Birmingham, Alabama;
Chicago, Illinois; Minneapolis, Minnesota; and Oakland,
California, USA.
Participants Black and white men and women aged 18-30
years with no glucose intolerance at baseline, including 1386
current smokers, 621 previous smokers, 1452 never smokers
with reported exposure to secondhand smoke (validated by
serum cotinine concentrations 1-15 ng/ml), and 1113 never
smokers with no exposure to secondhand smoke.
Main outcome measure Time to development of glucose
intolerance (glucose ≥ 100 mg/dl or taking antidiabetic drugs)
during 15 years of follow-up.
Results Median age at baseline was 25, 55% of participants
were women, and 50% were African-American. During
follow-up, 16.7% of participants developed glucose intolerance.
A graded association existed between smoking exposure and
the development of glucose intolerance. The 15 year incidence
of glucose intolerance was highest among smokers (21.8%),
followed by never smokers with passive smoke exposure
(17.2%), and then previous smokers (14.4%); it was lowest for
never smokers with no passive smoke exposure (11.5%).
Current smokers (hazard ratio 1.65, 95% confidence interval
1.27 to 2.13) and never smokers with passive smoke exposure
(1.35, 1.06 to 1.71) remained at higher risk than never smokers
without passive smoke exposure after adjustment for multiple
baseline sociodemographic, biological, and behavioural factors,
but risk in previous smokers was similar to that in never
smokers without passive smoke exposure.
Conclusion These findings support a role of both active and
passive smoking in the development of glucose intolerance in
young adulthood.
Introduction
Tobacco use has long been known to be a major risk factor for
cardiovascular disease,1 and recent studies have identified a posi-
tive association between smoking and incidence of diabetes.2–6
The evidence that smoking is an independent risk factor for the
development of diabetes is still considered preliminary.7 Some
studies have shown a dose-response association between
smoking and incidence of diabetes,4 5 but others have not.2 Also,
some earlier prospective research failed to find an increased risk
of diabetes among tobacco users.8 9
Several hypotheses have been proposed to link tobacco use
and incidence of diabetes. Smoking has been linked to impaired
response to glucose tolerance tests and insulin resistance.10 11
Although smoking cessation can result in modest weight gain,2
smoking is related to a more unhealthy distribution of upper
body weight and greater waist:hip ratio.12 Smoking has also been
associated with risk of chronic pancreatitis and pancreatic
cancer, suggesting that tobacco smoke may be directly toxic to
the pancreas.13
Previous studies have used only self report, were not
validated by biological measures such as cotinine, and have not
considered people with passive (secondhand) exposure to
tobacco. Also, previous studies have not included high
proportions of African-Americans, a population at particular
risk of developing diabetes.14 We used a population based longi-
tudinal study of African-American and white young adults in
four US cities to evaluate the association of smoking and passive
tobacco smoke exposure with risk of incident glucose
intolerance (impaired fasting glucose or diabetes) and to explore
potential causes of risk, including body weight distribution, insu-
lin resistance, and inflammation, by using stratified and
multivariate analyses. We hypothesised that current smokers
would have a higher incidence of impaired fasting glucose and
diabetes during follow-up than never smokers and that people
exposed to passive tobacco smoke would have an intermediate
risk.
Methods
Study design, participants, and measurements
The coronary artery risk development in young adults
(CARDIA) study is an ongoing prospective, multicentre study of
the natural history of the development of cardiovascular risk
from young adulthood to midlife. In 1985-6, 5115 black and
white men and women aged 18-30 years were recruited by ran-
dom selection of telephone numbers from designated census
tracts in Birmingham, Alabama; Chicago, Illinois; and Minne-
apolis, Minnesota, and by random selection from the
membership list of a healthcare plan in Oakland, California.
Only one participant per household was recruited, and the sam-
pling scheme was designed to achieve a balance at each of the
four sites by race (black, white), sex, education (high school
degree or less, more than high school), and age (18-24 years,
25-30 years). The baseline examination lasted four to five hours
and included blood pressure and anthropometric measure-
ments, phlebotomy for chemistries and lipids, urine collection,
lung function tests, and structured questionnaires on sociodemo-
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graphics, medical and family history, psychosocial characteris-
tics, and nutrition, among others. More detailed descriptions of
the sampling plan and initial cohort characteristics are available
elsewhere.15 16
Participants were contacted by telephone every year and seen
in person 2, 5, 7, 10, and 15 years after baseline for examinations
of similar length and slightly variable content, although the pro-
tocols for collection of key data elements remained constant over
time; re-examination rates among surviving cohort members
were 91%, 86%, 81%, 79%, and 74% at the five time points. Thus,
1321 (26%) of the original 5115 participants were lost to
follow-up by year 15.
Of 5115 CARDIA participants, 4903 had at least one
follow-up examination (212 participants never returned for any
follow-up examination and were excluded). For our analysis, we
further excluded 246 participants who had serum glucose level
≥ 100 mg/dl or were on antidiabetic drugs or did not have base-
line data on tobacco exposure, leaving 4657 participants with at
least one follow-up examination in the dataset.
Definition of baseline tobacco exposure (main independent variable)
Tobacco exposure was ascertained at all years through a
questionnaire administered by an interviewer.17 Participants self
reported current smoking, defined as regular cigarette smoking
(at least five cigarettes a week almost every week for at least three
months) at the time of a CARDIA examination. Previous smok-
ers were those who, at baseline, reported previously using
cigarettes but denied current smoking. Those who denied smok-
ing at baseline were also asked about history of passive exposure
to tobacco smoke.
A biochemical marker of nicotine uptake, serum cotinine,
was also measured at baseline. Baseline self report of current
cigarette smoking was validated against cotinine, and misclassifi-
cation was found to be low (1.3% under-reporting overall).18 For
participants who self reported being never smokers at baseline,
the tobacco exposure variable was defined as never smokers with
positive passive smoke exposure if participants reported having
had passive tobacco smoke exposure and they also had low coti-
nine concentrations (1-15 ng/ml) or never smokers with
negative passive smoke if participants denied passive smoke
exposure and cotinine was not detectable (0 ng/ml). In CARDIA
analyses, cotinine concentrations over 15 ng/ml have been used
to identify current smokers who denied smoking during the sur-
vey.18 Because of this, we excluded from the analysis a small
number of participants (n = 85) who reported passive smoke but
had cotinine levels > 15 ng/ml and were thus probably misclas-
sified current smokers,.
We thus divided 4572 participants into the four categories of
tobacco exposure by using this combination of self report and
serum cotinine measures at baseline: baseline current smokers,
previous smokers, never smokers with exposure to passive
smoke, and never smokers without reported passive smoke
exposure.
Definition of outcomes
For our main analysis, the outcome was time to development of
glucose intolerance. Fasting serum glucose was obtained at 7, 10,
and 15 years during follow-up. Guidelines from the American
Diabetes Association define impaired fasting glucose as serum
glucose ≥ 100 mg/dl and < 126 mg/dl and diabetes as fasting
serum glucose ≥ 126 mg/dl (or ≥ 6.93 mmol/l). We defined
development of glucose intolerance as having guideline defined
impaired fasting glucose or diabetes, or report of being
prescribed antidiabetic drugs, at any of the year 2, 5, 7, 10, or 15
examinations.
Covariates and potential mediating variables
The CARDIA database contains important sociodemographic,
health behaviour, physical examination, laboratory, and health
service related variables. Some variables were collected at
baseline, and others were collected at baseline and during
follow-up. Unless stated otherwise, we used baseline covariates
for the purpose of this analysis.
Baseline sociodemographic factors included self reported
ethnicity, age, sex, and years of education. Moderate alcohol con-
sumption has been inversely associated with risk of developing
diabetes.3 Mean daily ethanol intake was calculated by using the
following formula:mean ml ethanol per day = (usual number of
12 oz beers per week/7) × 16.7 ml + (usual number of 5 oz
glasses of wine per week/7 ) × 17.02 ml + (usual number of 1.5
oz distilled spirits per week/7) × 19.09.19
Self reported food intake was recorded as total calories of
food intake and total calories from fat per day. Physical activity
was measured by using the interviewer based CARDIA physical
activity history, which covers 13 different types of vigorous and
moderate intensity activities. The physical activity score was
calculated in exercise units reflecting the frequency and duration
of activity over the previous year.20
Number of pack years smoked was also collected at baseline
and all follow-up years. Baseline and follow-up physical
examination data included systolic blood pressure and hip and
waist circumference. Baseline and follow-up laboratory data
included serum insulin and serum triglycerides, a marker of the
metabolic syndrome that precedes diabetes. Additional prospec-
tive survey data collected from year 5 included household
income, having health insurance, and number of physician visits.
We included these variables as time dependent covariates.
On the basis of previous research, we postulated that baseline
serum insulin concentrations, as a marker for insulin resistance,
and waist:hip ratio, as a marker for central adiposity, might medi-
ate any association of tobacco smoke and risk of diabetes. Serum
C reactive protein, as a measure of inflammation, was not avail-
able at baseline, but was available at year 7. We assessed the
impact of these variables on the main hypothesis after first
adjusting for those variables that we considered potential
confounding covariates.
Data analysis
The major independent variable was tobacco exposure at
baseline.We first made individual comparisons for differences in
covariates for each category of tobacco exposure. The compari-
son group was always never smokers with no passive smoke
exposure, and we used t tests and 2 as appropriate. Similarly, we
used t tests and 2 as appropriate to assess the association of
tobacco exposure with possible variables within the causal path-
way between tobacco and risk of diabetes (waist:hip ratio, serum
insulin during follow-up, and C reactive protein at year 7).
To determine whether current smoking, previous smoking,
and passive exposure to tobacco smoke were related to a greater
risk of development of glucose intolerance, we used Kaplan-
Meier analysis to assess the incidence of glucose intolerance. We
compared the incidence of glucose intolerance by tobacco expo-
sure at baseline by using log rank tests. We also subsequently
used additional Kaplan-Meier curves to assess the incidence of
diabetes.
We developed multivariate Cox proportional hazards models
to adjust the association between levels of smoke exposure and
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incidence of glucose intolerance for various potential confound-
ers. Exploratory analysis confirmed the appropriateness of mod-
elling continuous variables as linear. The initial model included
sociodemographic factors: ethnicity, sex, age, years of education,
and income (time dependent). We then developed additional
models to include physical and laboratory covariates (systolic
blood pressure, serum triglycerides), health behaviours (physical
activity, alcohol intake, total and saturated fat intake), and health
service related variables (number of physician visits per year,
(time dependent) health insurance status). The next model
(reported below as the primary model) included all the
covariates listed above that were found to differ significantly by
tobacco exposure and was further adjusted for time dependent
change in smoking (stopping or starting). We then repeated
these analyses with diabetes (defined as fasting serum glucose
> 126 mg/dl or prescribed antidiabetic drugs) as the outcome.
We also introduced potential mediating factors (baseline
waist:hip ratio and insulin concentration, year 7 C reactive
protein) into subsequent models to evaluate for further attenua-
tion of the main effect. To evaluate the potential dose-response
effect of greater smoke exposure, we did an analysis using time
dependent number of pack years smoked as a continuous main
independent variable in additional models adjusted as for those
described above.
Results
Among the 4572 participants, we identified a total of 1386 cur-
rent smokers at baseline, 621 previous smokers, 1452 never
smokers with reported passive tobacco smoke exposure or coti-
nine concentration 1-15 ng/ml, and 1113 never smokers with no
passive tobacco smoke exposure reported (table 1). The 1386
current smokers smoked a mean of 10 (SD 8.7, range 0-62.5)
cigarettes a day. The 1452 never smokers with positive passive
smoke were exposed to a mean of 12.6 (SD 18.0) hours of smoke
a week. At baseline, the mean age of participants was 25 (SD 3.6)
years, 2529 (55%) were women, and 2283 (50%) were
African-American. Smokers and never smokers with passive
smoke exposure were more likely to be African-American and
less likely to be women than were never smokers with no passive
smoke exposure (table 1). Current smokers also had lower edu-
cation, drank more alcohol, and had higher fat intake compared
with never smokers with no passive smoke.
Incidence of glucose intolerance and smoking or tobacco
smoke exposure
In Kaplan-Meier analysis, overall incidence of glucose intoler-
ance was 9.2% (95% confidence interval 8.4% to 10.1%) at 7
years of follow-up, 12.8% (11.9% to 13.9%) at 10 years, and 16.7%
(15.5% to 17.8%) at 15 years. Fifteen year Kaplan-Meier
incidence of diabetes during follow-up was 3.1% (2.6% to 3.7%).
Across categories of tobacco exposure, 15 year incidence of glu-
cose intolerance was greatest among current smokers and lowest
among never smokers with no exposure to passive smoke (table
2). Never smokers with exposure to passive tobacco smoke had
an intermediate incidence. The risk of previous smokers was sta-
tistically similar to that of never smokers with no passive smoke
exposure.
In the primary Cox proportional hazards model, current
smokers had a higher risk of glucose intolerance than never
smokers with no passive smoke exposure, after adjustment for
baseline sociodemographic factors (age, sex, race, years of
education, family income (year 5)) and for baseline biological
and behavioural factors—systolic blood pressure, triglycerides,
alcohol consumption, body mass index, and change in smoking
(starting for never smokers and previous smokers and stopping
for current smokers) collected during follow-up (table 3). Never
smokers with positive passive smoke exposure also had a greater
risk of developing glucose intolerance, compared with never
smokers with no positive passive smoke after adjustment.
In a separate proportional hazards model, the unadjusted
point estimate of the risk of development of diabetes was 1.58
(95% confidence interval 0.94 to 2.63) for smokers and 1.40
(0.84 to 2.33) for never smokers with positive passive smoker
exposure, compared with never smokers with no passive smoke
exposure. Further adjustment for variables as in the primary
model did not alter the significance or direction of these results.
Pack years as a marker for amount of tobacco exposure
Consistent with our primary analysis, increasing pack years of
smoking over time among the 4572 participants was associated
with an increased risk of developing glucose intolerance. After
adjustment, for every increase in 10 pack years of smoking the
risk of developing glucose intolerance increased by 18% (hazard
ratio 1.18, 1.02 to 1.36).
Incidence of glucose intolerance by race-sex subgroups
Incidence of glucose intolerance by tobacco exposure varied
among race-sex subgroups (table 4). The association between
current smoking and glucose intolerance seemed to be stronger
in white people than in black people for both women and men
(P < 0.001 for overall interaction with race-sex).
Table 1 Baseline characteristics of 4572 CARDIA participants by baseline
(1985-6) tobacco exposure. Values are mean (SD) unless stated otherwise
Characteristic
Current
smokers
(n=1386)
Previous
smokers
(n=621)
Never smokers,
passive smoke
exposure
(n=1452)
Never
smokers, no
passive smoke
(n=1113)
Baseline age (years)*† 25 (3.6) 26 (3.2) 24 (3.7) 25 (3.6)
No (%)
African-American*†‡
773 (56) 207 (33) 856 (59) 453 (41)
No (%) women‡ 729 (53) 359 (58) 781 (54) 660 (59)
No (%) with less than
high school
education*†‡
789 (57) 213 (34) 508 (35) 245 (22)
No (%) with income at
least $35 000*†‡
379 (32) 264 (48) 548 (43) 557 (55)
Baseline physical activity
score
403 (294) 438 (284) 426 (316) 415 (285)
Baseline daily total caloric
intake (kcal)*†‡
3365
(2063)
2685
(1308)
2880 (1514) 2548 (1393)
Baseline daily saturated
fat caloric intake
(kcal)*‡
55 (37) 42 (25) 46 (27) 40 (27)
Baseline alcohol
consumption
(ml/day)*†‡
20 (31) 13 (19) 8 (15) 6 (10)
Baseline systolic blood
pressure (mm Hg)*
110 (11) 109 (11) 111 (11) 110 (11)
Baseline triglycerides
(mmol/l)*†‡
0.85 (0.55) 0.81 (0.57) 0.74 (0.45) 0.73 (0.42)
Physician visits per year 1.6 (0.5) 1.7(0.5) 1.7 (0.5) 1.7 (0.5)
No (%) with health
insurance*†‡
803 (73) 416 (81) 996 (83) 861 (88)
Baseline waist:hip ratio*†‡ 0.79 (0.07) 0.77 (0.07) 0.77 (0.07) 0.77 (0.07)
Baseline serum insulin‡ 9.9 (7.0) 10.2 (7.7) 11.4 (8.2) 10.8 (8.1)
C reactive protein at seven
year follow-up‡
3.4 (6.7) 3.2 (16) 2.6 (3.6) 2.5 (4.6)
All variables measured at baseline (1985-6), except for income measured at year 5 and health
insurance measured at year 7.
*P<0.05 for never smokers with passive smoke exposure versus never smokers with no
passive smoke exposure.
†P<0.05 for previous smokers versus never smokers with no passive smoke exposure.
‡P<0.05 for current smokers versus never smokers with no passive smoke exposure.
Research
BMJ Online First bmj.com page 3 of 6
Impact of potential mediators—waist:hip ratio and baseline
insulin
Waist:hip ratio, used as a time dependent variable, was associated
with increased risk of developing glucose intolerance. Each
increase in the ratio by 0.01 unit was associated with an increase
of 8% in risk of glucose intolerance (hazard ratio 1.08, 1.08 to
1.09). Serum insulin (hazard ratio per 1 ng/dl increase 1.04, 1.03
to 1.04) and year 7 C reactive protein (hazard ratio per 10 mg/dl
increase 1.08, 1.04 to 1.12) were also associated with increased
risk. When waist:hip ratio was added into the primary adjusted
model above, the associations of increased incidence of glucose
intolerance with current smoking (hazard ratio 1.53, 1.18 to 1.99)
and passive smoke exposure among never smokers (1.28, 1.01 to
1.62) were essentially unchanged. When serum insulin and C
reactive protein, and subsequently all three variables, were
added, the associations were again essentially unchanged,
although significance for never smokers with passive smoke
exposure was borderline (hazard ratio 1.26, 0.99 to 1.61;
P = 0.06).
Discussion
In this 15 year prospective study, both current smoking and
exposure to passive tobacco smoke at baseline were positively
associated with increased risk of developing glucose intolerance.
These effects were robust to multivariate adjustment. Use of pack
years of smoking showed a consistent dose-response effect of
increasing risk with increasing exposure to tobacco.
Passive exposure to smoke among never smokers conferred
an intermediate risk (hazard ratio 1.35) between current smokers
(hazard ratio 1.65) and never smokers with no exposure (hazard
ratio 1.0, reference) for glucose intolerance, in univariate
analysis. The point estimate of risk was greater among never
smokers with positive passive smoke exposure than among pre-
vious smokers, both before and after multivariate adjustment.
Passive smoke contains similar toxins to active smoke but is pro-
duced at different temperatures and different reducing
conditions, so some toxic substances are even more concentrated
in passive smoke.21–23 If one of these concentrated toxins is
related to the hypothesised pancreatic toxicity, this might explain
the increased risk in passive smokers, although they have less
overall exposure than current smokers.
Table 2 Prospective 5, 7, 10, and 15 year incidences (percentages) of glucose intolerance by baseline tobacco exposure: CARDIA study, 1985-2001
Interval
Never smokers, no passive smoke
exposure
Never smokers, passive smoke
exposure Previous smokers Current smokers
No* Incidence (95% CI)† No* Incidence (95% CI)†‡ No* Incidence (95% CI)†§ No* Incidence (95% CI)†‡
5 year 1077 0.3 (0 to 1) 1390 0.1 (0 to 1) 593 0.3 (0 to 1) 1303 0.1 (0 to 1)
7 year 1044 6 (5 to 8) 1338 9 (7 to 10) 563 8 (6 to 10) 1237 13 (11 to 15)
10 year 930 10 (8 to 11) 1164 13 (11 to 15) 485 12 (9 to 15) 1016 16 (14 to 19)
15 year 828 11 (10 to 14) 981 17 (15 to 19) 414 14 (12 to 18) 801 22 (19 to 24)
Incidences derived from Kaplan-Meier analysis (see methods section). Participants at risk in all categories of smoking exposure: 2 years=4572; 5 years=4363; 7 years=4182; 10 years=3595; 15
years=3024.
*Number of participants at risk at each interval.
†Incidence is cumulative Kaplan-Meier survival incidence calculated over full data and evaluated at indicated times.
‡Log rank test (compared with never smokers, with no passive smoke exposure) P<0.001.
§Log rank test (compared with never smokers, with no passive smoke exposure) P=0.11.
Table 3 Association of smoking and passive tobacco smoke with incidence
of glucose intolerance over 15 years of follow-up among 4572 CARDIA
participants: unadjusted and adjusted hazard ratios from Cox proportional
hazards analysis
Unadjusted hazard ratio (95%
CI)
Adjusted hazard
ratio* (95% CI)
Never smoker, no passive smoke
exposure
Reference Reference
Never smoker, passive smoke
exposure
1.50 (1.20 to 1.88) 1.35 (1.06 to 1.71)
Previous smoker 1.26 (0.94 to 1.68) 1.17 (0.86 to 1.57)
Current smoker 1.94 (1.56 to 2.42) 1.65 (1.27 to 2.13)
Sociodemographic characteristics
African-American (v white) 1.38 (1.18 to 1.60) 1.42 (1.19 to 1.69)
Male (v female) 2.38 (2.03 to 2.79) 1.94 (1.61 to 2.35)
Baseline age (per 10 years) 1.57 (1.25 to 1.97) 1.70 (1.34 to 2.15)
Education (at least high school v less
than high school)
0.77 (0.66 to 0.90) 0.83 (0.69 to 1.00)
Income (per $5000) 0.96 (0.92 to 0.99) 0.99 (0.94 to 1.03)
Health behaviours
Daily total caloric intake (per 1000
kcals)
1.06 (1.03 to 1.10) 0.99 (0.94 to 1.03)
Daily saturated fat caloric intake (per
100 kcals)
1.43 (1.17 to 1.74) 1.61 (0.79 to 3.35)
Alcohol intake (per 100 ml/day) 1.80 (1.41 to 2.30) 1.05 (0.74 to 1.49)
Physical and laboratory tests
Triglycerides (per 1.1 mmol/l) 1.35 (1.30 to 1.40) 1.30 ( 1.24 to 1.37)
Systolic blood pressure (per mm Hg) 1.04 (1.03 to 1.04) 1.02 (1.01 to 1.03)
Health service related
Has health insurance (v no health
insurance)
0.98 (0.83 to 1.17) 1.10 (0.92 to 1.34)
*From Cox proportional hazards model adjusted for all variables in table and change in
smoking (stopping or starting) during follow-up.
Table 4 Stratified analysis by race and sex of 15 year Kaplan-Meier
incidence and proportional hazards of glucose intolerance by tobacco
exposure: CARDIA study, 1985-2001
African-American
men
African-American
women White men
White
women
Current smokers
15 year incidence of
glucose intolerance (%)
29.9 19.1 30.5 9.2
Unadjusted hazard ratio
(95% CI)
1.49
(0.99 to 2.24)
1.55
(1.01 to 2.38)
2.12
(1.44 to 3.13)
2.15
(1.14 to 4.07)
Adjusted hazard ratio (95%
CI)
1.43
(0.88 to 2.35)
1.30
(0.79 to 2.20)
1.99
(1.25 to 3.16)
1.31
(0.63 to 2.75)
Previous smokers
Incidence (%) 25.7 18.0 20.3 5.0
Unadjusted hazard ratio
(95% CI)
1.22
(0.69 to 2.17)
1.49
(0.83 to 2.67)
1.38
(0.86 to 2.23)
1.17
(0.54 to 2.55)
Adjusted hazard ratio (95%
CI)
1.26
(0.68 to 2.30)
1.38
(0.74 to 2.56)
1.15
(0.69 to 1.91)
0.91
(0.42 to 2.01)
Never smokers, passive smoke exposure
Incidence (%) 24.4 11.8 24.3 10.0
Unadjusted hazard ratio
(95% CI)
1.18
(0.78 to 1.79)
0.93
(0.59 to 1.46)
1.65
(1.11 to 2.44)
2.31
(1.22 to 4.36)
Adjusted hazard ratio (95%
CI)
1.26
(0.80 to 1.97)
0.97
(0.60 to 1.56)
1.66
(1.11 to 2.49)
1.89
(0.98 to 3.64)
Never smokers, no passive smoke exposure (reference)
Incidence (%) 20.4 12.6 14.7 4.3
Adjusted hazard ratios from separate logistic regression analyses (stratified by race and sex)
and adjusted for sociodemographic factors (age, sex, race, years of education, income), as
well laboratory, biological, and behavioural factors: systolic blood pressure, triglycerides,
alcohol consumption, and smoking pack years collected during follow-up.
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Comparison with previous studies
Early studies evaluating an association of tobacco and risk of dia-
betes were negative,8 9 but more recent studies have shown posi-
tive associations.2–6 The fact that passive tobacco smoke exposure
is an independent risk for glucose intolerance is, to our
knowledge, new information. We found that people with passive
exposure to tobacco smoke had an intermediate risk between
current smokers and never smokers without passive smoke
exposure. In fact, the risk of developing glucose intolerance for
people with passive tobacco smoke exposure was similar to that
of those who were previous smokers.
Our finding that the association of glucose intolerance with
smoking varies across race-sex groups also adds to the previous
literature. In the race and sex stratified analyses, the risks of glu-
cose intolerance associated with tobacco exposure were greater
in men than in women and greater in white people than in black
people. The hazard ratio for passive smoking exposure was
significant only for white men, although the decreases in sample
size that accompany these stratified analyses need to be consid-
ered in the interpretation of these results.
Causal pathways
We explored potential causal pathways of tobacco exposure and
incident diabetes. The main association of tobacco exposure and
incidence of glucose intolerance was unchanged after introduc-
ing waist:hip ratio, baseline insulin levels, or C reactive protein
into the analysis. As expected, waist:hip ratios were less
favourable among smokers. However, addition of this factor to
the model did not substantially attenuate the main association of
smoking and glucose intolerance. This suggests that the underly-
ing association, if causal, is not moderated by the effect of smok-
ing on fat distribution.
We considered access to health care, socioeconomic factors,
and unhealthy eating patterns as potential confounders of the
association between smoking exposure and glucose intolerance.
A previous study using CARDIA data has identified a strong
association between tobacco exposure and lack of health
insurance.24 Smoking could thus be a marker for healthcare
access variables. Although health insurance status and number
of visits to the physician were not available at baseline,
adjustment for these variables measured at years 5 and 7 did not
change our results. Consistent with many other studies, we found
that tobacco exposure was strongly associated with education
and income. Of note, in another CARDIA analysis, the socioeco-
nomic variables that we used here were sufficient to show that
ethnic differences in smoking status are mostly explained by
socioeconomic factors.17 Smoking may also be marker for other
unhealthy behaviours such as a high fat, high calorie diet, which
may also predispose to diabetes.25 The fact that our main associa-
tions persisted after adjustments for variables attempting to cap-
ture these socioeconomic and behavioural constructs does not
rule out potential residual confounding, which is a possible limi-
tation of our study.
Limitations
The above notwithstanding, the observational nature of our
study is its major limitation, precluding definitive causal
inferences. Also, the CARDIA cohort represents African-
Americans and white people recruited from four urban areas in
the United States. Our results are not necessarily generalisable to
other ethnic minorities, rural areas, or other populations.
Conclusion
In summary, we found that tobacco exposure is associated with
the development of glucose intolerance over a 15 year period,
with a dose-response effect apparent. Importantly, we identified
passive tobacco exposure in never smokers as a new risk factor
for glucose intolerance. If confirmed by further research, these
findings provide further documentation of the deleterious
effects of tobacco smoking, and policy makers may use them as
additional justification to reduce exposure to passive smoke.
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